Claims
- 1. An implant material which comprises, as a base material, a biocompatible bulk structure of a tri-axial or more three-dimensionally woven fabric of organic fibers, a tri-axial or more three-dimensionally knitted fabric of organic fibers or a combination thereof.
- 2. The implant material according to claim 1, wherein a void ratio in the fabric of the bulk structure is in the range of from 20 to 90 vol %.
- 3. The implant material according to claim 1 or 2, wherein the organic fibers which constitute the bulk structure are bioinert fibers or fibers having a surface coated with a bioinert polymer.
- 4. The implant material according to claim 1, wherein the organic fibers which constitute the bulk structure are bioactive or bioaffinitive fibers.
- 5. The implant material according to claim 1, wherein the organic fibers which constitute the bulk structure are biologically degradable and absorbable fibers.
- 6. The implant material according to claim 3, wherein the bulk structure has a surface that is biologically activated.
- 7. The implant material according to claim 6, wherein the bulk structure has a surface that is biologically activated by grafting it with a monomer or an oligomer having an organic phosphate group.
- 8. The implant material according to claim 6, wherein the bulk structure has a surface that is biologically activated by coating it with a biologically degradable and absorbable polymer containing a bioactive substance.
- 9. The implant material according to claim 6, wherein the bulk structure has a surface that is biologically activated by coating it with a polymer containing a bioactive substance and scraping off the surface of said polymer to expose the bioactive substance.
- 10. The implant material according to claim 8 or 9, wherein said bioactive substance is at least one substance selected from the group consisting of bioglass, ceravital, hydroxyapatite and AW glass ceramics.
- 11. The implant material according to claim 6, wherein the bulk structure has a surface that is biologically activated by immobilizing a natural biomaterial to the surface thereof.
- 12. The implant material according to claim 11, wherein said natural biomaterial is at least one substance selected from the group consisting of collagen, gelatin, fibronectin, hyaluronic acid, thrombomodulin, hydroxyapatite, urokinase and heparin.
- 13. The implant material according to claim 3, wherein the bulk structure has a surface that is biologically inactivated by immobilizing a highly hydrophilic hydrogel to the surface thereof.
- 14. The implant material according to claim 13, wherein said highly hydrophilic hydrogel is at least one gel selected from the group consisting of gelatin, methylcellulose, hydroxypropylmethylcellulose, alginic acid, agar, carrageenan, proteoglycan, hyaluronic acid, collagen, fibrin, casein, polyvinyl alcohol gels, polyethylene oxide gels and polyhydroxymethacrylic acid base gels.
- 15. The implant material according to any one of claims 1 to 14, wherein a matrix of the same or different organic fibers is filled in a fabric space of the bulk structure.
- 16. The implant material according to claim 15, wherein the bulk structure is compression-molded.
Priority Claims (1)
Number |
Date |
Country |
Kind |
5-261582 |
Sep 1993 |
JPX |
|
Parent Case Info
This is a continuation-in-part application of PCT/JP94/01565, filed Sep. 22, 1994.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
3987797 |
Stephenson |
Oct 1976 |
|
4089071 |
Kalnberz et al. |
May 1978 |
|
Foreign Referenced Citations (8)
Number |
Date |
Country |
0338976 |
Oct 1989 |
EPX |
0366018 |
May 1990 |
EPX |
0511686 |
Nov 1992 |
EPX |
0560279 |
Sep 1993 |
EPX |
2635966 |
Mar 1990 |
FRX |
3042003 |
Jul 1982 |
DEX |
04129564 |
Apr 1992 |
JPX |
2215209 |
Sep 1989 |
GBX |
Non-Patent Literature Citations (1)
Entry |
"Design and In Vitro Testing of Newly Made Biocomponent Fabrics for Vascular Surgery", Chu et al, Polymer. Mater. Sci. Eng. (1985), 53, 400-4. |